Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 7.71
-0.18 (-2.28%)
Jun 9, 2026, 3:00 PM CST
SHA:603707 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SHA:603707 stock has a consensus rating of "Strong Buy" and an average price target of ¥11.94. The average 1-year stock price forecast is 54.86% higher than the current stock price, while the lowest is ¥10.83 (+40.47%) and the highest is ¥13.00 (+68.61%).
Price Target: ¥11.94 (+54.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:603707 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
4.49B
from 3.99B
Increased by 12.57%
Revenue Next Year
5.35B
from 4.49B
Increased by 19.02%
EPS This Year
0.38
from 0.31
Increased by 22.11%
EPS Next Year
0.48
from 0.38
Increased by 26.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.5B | ||
| Avg | 4.5B | ||
| Low | 4.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.9% | ||
| Avg | 12.6% | ||
| Low | 11.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.38 | ||
| Avg | 0.38 | ||
| Low | 0.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22.1% | ||
| Avg | 22.1% | ||
| Low | 22.1% |